Novo Nordisk

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments.

CEO

Maziar Mike Doustdar

CEOMaziar Mike Doustdar

Employees

68,794

Employees68,794

Headquarters

Bagsværd, Capital Region

HeadquartersBagsværd, Capital Region

Founded

1923

Founded1923

Employees

68,794

Employees68,794

NVO Key Statistics

Market cap

178.52B

Market cap178.52B

Price-Earnings ratio

10.34

Price-Earnings ratio10.34

Dividend yield

2.99%

Dividend yield2.99%

Average volume

13.29M

Average volume13.29M

High today

$41.39

High today$41.39

Low today

$40.08

Low today$40.08

Open price

$40.93

Open price$40.93

Volume

13.52M

Volume13.52M

52 Week high

$64.16

52 Week high$64.16

52 Week low

$35.12

52 Week low$35.12

NVO News

Investing.com 5h

Novo Nordisk partners with DJ Khaled for Wegovy campaign - Investing.com

...

The Motley Fool 19h

JPMorgan Predicted Strong Wegovy Pill Sales (and Was Right). Is Novo Nordisk Stock a Buy Now?

Novo Nordisk (NVO +0.96%) received a vote of confidence from JPMorgan Chase's (JPM +0.39%) analyst ahead of the drug maker's earnings report. The analyst was ex...

Simply Wall St 23h

Novo Nordisk Stock May Trade Below Fair Value Following Raised Outlook

has seen a sharp reset in its share price over the past few years, even as it remains in the spotlight for obesity and diabetes treatments. With the stock now a...

Analyst ratings

50%

of 8 ratings

Buy

25%

Hold

50%

Sell

25%

More NVO News

24/7 Wall St. 1d

Hims & Hers Climbs 6% Despite Five States Joining FTC Suit; Eli Lilly Dips, Novo Nordisk Holds Steady

It sounds nuts, but SoFi is giving new Active Invest users up to $1,000 in stock for a limited time, and all it takes is a $50 deposit to get started. See for y...

24/7 Wall St. 2d

Hims & Hers Drops 18% as Q3 Loss and Profit Outlook Cut Disappoint; Novo Nordisk Slides 2%, Eli Lilly Holds Steady

It sounds nuts, but SoFi is giving new Active Invest users up to $1,000 in stock for a limited time, and all it takes is a $50 deposit to get started. See for y...

The Motley Fool 2d

Eli Lilly vs Novo Nordisk: What's the Better GLP-1 Stock to Buy?

Eli Lilly (LLY +0.54%) and Novo Nordisk (NVO -1.97%) are leading drugmakers in the highly lucrative GLP-1 market, where demand is through the roof for weight lo...

MarketWatch 3d

Ozempic, Zepbound and other GLP-1 drugs have a possible risk of vision loss

The U.S. will now require companies that sell GLP-1 medications like Ozempic and Zepbound to include a warning about the possible risk of vision loss. Several...

The Motley Fool 3d

Eli Lilly Is Now Worth Nearly 9 Novo Nordisks. Here's How the Gap Got So Wide.

Eli Lilly (LLY -0.79%) and Novo Nordisk (NVO +0.03%) both participate in one of the biggest pharma growth markets today, and that's the weight loss drug market....

Seeking Alpha 4d

Novo Nordisk reports liver improvements with Wegovy in some patients

Novo Nordisk (NVO) said Sunday that its weight-loss drug Wegovy was associated with improvements in several measures of liver health among patients with a serio...

The Motley Fool 5d

Novo Nordisk Just Delivered Great News for Investors. Is a Comeback Finally Underway?

Are things finally starting to look up for Novo (NVO +0.03%)? The Denmark-based pharmaceutical leader has had a rough past couple of years, but its third-quarte...

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.